Food and Drug Administration (FDA)

The Safeguarding Women from Chemical Abortion Act, if enacted, would revoke the Food and Drug Administration’s approval of the drug.

DOJ lawyers in the Trump administration argued in the filing that the court “should either stay this case until after FDA completes its review or dismiss it.”

Lawyers for Louisiana asked a federal judge Feb. 24 to roll back relaxed restrictions on mifepristone, a drug commonly, but not exclusively, used for abortion.

A key national pro-life group released polling it said shows a potential failure to act on pro-life policy priorities may demotivate Republican primary voters in the upcoming midterm elections. 

A key pro-life group said the Justice Department is undermining Louisiana’s efforts to roll back the Biden administration’s restrictions on the abortion pill.

A “complex” political environment presents both challenge and opportunity for the pro-life movement, said Jennie Bradley Lichter.

In a press call just before the 53rd annual March for Life, a key national pro-life organization pushed the Trump administration to safeguard the Hyde Amendment and reinstate stronger restrictions …

A Senate committee held a hearing on the abortion pill Jan. 14 as the Trump administration faces scrutiny from some pro-lifers over the Food and Drug Administration’s recent approval of …

U.S. Senate rejects dueling health care bills Dec. 11. The Democratic and GOP-led bills didn’t reach the chamber’s 60-vote filibuster threshold to advance. 

“The FDA is doing nothing while every single day abortion drugs take the lives of children, put women and girls at serious risk.”